BTR Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $20.7M | Sell |
40,843
-103
| -0.3% | -$57.6K | 3.24% | 5 |
|
|
2022
Q2 | $22.3M | Sell |
40,946
-387
| -0.9% | -$213K | 3.2% | 4 |
|
|
2022
Q1 | $24.4M | Sell |
41,333
-598
| -1% | -$344K | 3% | 7 |
|
|
2021
Q4 | $28M | Sell |
41,931
-682
| -2% | -$426K | 3.16% | 6 |
|
|
2021
Q3 | $24.3M | Sell |
42,613
-3,217
| -7% | -$1.77M | 3.02% | 6 |
|
|
2021
Q2 | $23.1M | Buy |
45,830
+749
| +2% | +$353K | 2.89% | 8 |
|
|
2021
Q1 | $20.6M | Sell |
45,081
-505
| -1% | -$241K | 2.99% | 8 |
|
|
2020
Q4 | $21.2M | Sell |
45,586
-539
| -1% | -$253K | 3.32% | 6 |
|
|
2020
Q3 | $20.4M | Sell |
46,125
-2,131
| -4% | -$880K | 3.6% | 3 |
|
|
2020
Q2 | $17.5M | Sell |
48,256
-85
| -0.2% | -$28.5K | 3.28% | 5 |
|
|
2020
Q1 | $13.7M | Sell |
48,341
-13
| -0% | -$4.1K | 3.03% | 9 |
|
|
2019
Q4 | $15.7M | Sell |
48,354
-365
| -0.7% | -$111K | 2.71% | 8 |
|
|
2019
Q3 | $14.2M | Sell |
48,719
-5,921
| -11% | -$1.7M | 2.67% | 9 |
|
|
2019
Q2 | $16M | Sell |
54,640
-1,996
| -4% | -$550K | 2.99% | 7 |
|
|
2019
Q1 | $15.5M | Sell |
56,636
-3,666
| -6% | -$912K | 2.98% | 7 |
|
|
2018
Q4 | $13.5M | Sell |
60,302
-3,525
| -6% | -$827K | 2.84% | 9 |
|
|
2018
Q3 | $15.6M | Sell |
63,827
-1,241
| -2% | -$285K | 2.71% | 8 |
|
|
2018
Q2 | $13.5M | Sell |
65,068
-403
| -0.6% | -$85.5K | 2.6% | 10 |
|
|
2018
Q1 | $13.5M | Sell |
65,471
-1,610
| -2% | -$338K | 2.7% | 7 |
|
|
2017
Q4 | $12.7M | Sell |
67,081
-664
| -1% | -$127K | 2.49% | 10 |
|
|
2017
Q3 | $12.8M | Sell |
67,745
-827
| -1% | -$150K | 2.61% | 7 |
|
|
2017
Q2 | $12M | Sell |
68,572
-1,079
| -2% | -$181K | 2.45% | 10 |
|
|
2017
Q1 | $10.7M | Buy |
69,651
+3,324
| +5% | +$508K | 2.24% | 13 |
|
|
2016
Q4 | $10.6M | Hold |
66,327
| – | – | 2.37% | 10 |
|
|
2016
Q3 | $10.6M | Sell |
66,327
-5,153
| -7% | -$794K | 2.37% | 10 |
|
|
2016
Q2 | $10.6M | Sell |
71,480
-935
| -1% | -$138K | 2.42% | 11 |
|
|
2016
Q1 | $10.3M | Sell |
72,415
-5,635
| -7% | -$755K | 2.38% | 11 |
|
|
2015
Q4 | $11.1M | Sell |
78,050
-865
| -1% | -$115K | 2.52% | 6 |
|
|
2015
Q3 | $9.65M | Buy |
78,915
+200
| +0.3% | +$26.1K | 2.31% | 8 |
|
|
2015
Q2 | $10.2M | Buy |
78,715
+3,902
| +5% | +$509K | 2.4% | 9 |
|
|
2015
Q1 | $10.1M | Buy |
74,813
+4,825
| +7% | +$622K | 2.44% | 7 |
|
|
2014
Q4 | $8.77M | Buy |
69,988
+5,290
| +8% | +$643K | 2.39% | 10 |
|
|
2014
Q3 | $7.87M | Sell |
64,698
-90
| -0.1% | -$10.9K | 2.17% | 13 |
|
|
2014
Q2 | $7.64M | Sell |
64,788
-360
| -0.6% | -$42.4K | 2.1% | 14 |
|
|
2014
Q1 | $7.83M | Sell |
65,148
-15,150
| -19% | -$1.8M | 2.28% | 11 |
|
|
2013
Q4 | $8.94M | Sell |
80,298
-8,410
| -9% | -$836K | 2.55% | 5 |
|
|
2013
Q3 | $8.17M | Sell |
88,708
-10,410
| -11% | -$941K | 2.57% | 8 |
|
|
2013
Q2 | $8.39M | Buy |
+99,118
| New | +$8.25M | 2.61% | 7 |
|
Other funds holding TMO
BTR Capital Management's TMO Position: Q3 2022 in Review
BTR Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.25% in Q3 2022, selling an estimated $57.6K and leaving 40,843 shares worth $20.7M. The position accounts for 3.24% of the portfolio, ranked #5.
BTR Capital Management first reported a position in TMO in Q2 2013 and has held it in 38 quarters since. The position peaked at $28M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- BTR Capital Management held 40,843 shares of Thermo Fisher Scientific worth $20.7M as of Q3 2022.
- BTR Capital Management sold 103 Thermo Fisher Scientific shares in Q3 2022, an estimated $57.6K.
- Thermo Fisher Scientific made up 3.24% of BTR Capital Management's portfolio in Q3 2022, its #5 holding.
- BTR Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's Thermo Fisher Scientific position peaked at $28M in Q4 2021.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.